SCHEMBL7495381

SCHEMBL7495381

CS(=O)(=O)OC[C@H]1CN(Cc2ccccc2)CC(=O)N1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.38
RECQL P46063 1/20 0.38
ALDH1A1 P00352 3/20 0.37
LTA4H P09960 1/20 0.37
CXCR4 P61073 2/20 0.37
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
GAA P10253 2/20 0.36
PTPN1 P18031 1/20 0.36
HTR2A P28223 1/20 0.36
DRD2 P14416 1/20 0.36
ACHE P22303 2/20 0.35
PAX8 Q06710 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7495387 1.00 SMN1; SMN2 (0.38) SMN1; SMN2RECQLALDH1A1LTA4HCXCR4
SCHEMBL26690669 0.80 ALOX5 (0.47) ALDH1A1KMT2AMEN1SIGMAR1GAA
SCHEMBL26690672 0.80 ALOX5 (0.47) ALDH1A1KMT2AMEN1SIGMAR1GAA
SCHEMBL4068578 0.79 TOP2A (0.36) ALDH1A1LTA4HSIGMAR1GAAACHE
SCHEMBL4072649 0.78 SIGMAR1 (0.46) ALDH1A1KMT2AMEN1SIGMAR1FUCA1
SCHEMBL20304604 0.78 SIGMAR1 (0.46) ALDH1A1KMT2AMEN1SIGMAR1FUCA1
SCHEMBL4072653 0.78 SIGMAR1 (0.46) ALDH1A1KMT2AMEN1SIGMAR1FUCA1
SCHEMBL6997546 0.76 GBA1 (0.46) SMN1; SMN2RECQLKMT2AMEN1CYP2D6
SCHEMBL6997539 0.76 GBA1 (0.46) SMN1; SMN2RECQLKMT2AMEN1CYP2D6
SCHEMBL3318031 0.74 ACHE (0.46) SIGMAR1GAAACHEFUCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1208097-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS Aventis Pharmaceuticals Inc. (US) 2002-05-29 EP disclosed
WO-2001007436-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS AVENTIS PHARMACEUTICALS INC. (US) 2001-02-01 WO disclosed